Vectus Biosystems Limited
ASX:VBS.AX
0.08 (AUD) • At close September 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.648 | 0.775 | 0.579 | 1.3 | 0 | 0 | 0.05 | 0.051 | 0 | 0 | 0 | 0.001 | 0.001 | 0.018 | 0.031 | 0.063 | 0 | 0.012 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.03 | 0.029 | 0.025 | 0.022 | 0.014 | 0.006 | -0.968 | 0.009 | 0.01 | 0.009 | 0.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.03 | 0.619 | 0.75 | 0.557 | 1.286 | -0.006 | 0.968 | 0.042 | 0.041 | -0.009 | -0.012 | 0 | 0.001 | 0.001 | 0.018 | 0.031 | 0.063 | 0 | 0.012 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.956 | 0.968 | 0.962 | 0.989 | -78.926 | 5,376.128 | 0.829 | 0.797 | -41.018 | -90.109 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.537 | 0.614 | 0.717 | 1.241 | 1.33 | 1.206 | 0.989 | 0.727 | 0.479 | 0.234 | 0.427 | 0.285 | 0.529 | 1.074 | 0.948 | 1.308 | 1.013 | 0.371 | 0.471 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0.43 | 0.439 | 0.491 | 0.356 | 0.378 | 0.36 | 0.54 | 0.286 | 0.342 | 0.22 | 0.298 | 0.315 | 0.348 | 0.325 | 0.366 | 0.093 | 0.58 | 0.084 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0.751 | 0.9 | 0.763 | 0.627 | 0.682 | 0.766 | 0.407 | 0.709 | 0.645 | 0.369 | 0.752 | 0.841 | 0.868 | 0.971 | 0.919 | 1.182 | 0 | 0.962 | 0 | 0 | 0 | 0 |
| SG&A
| 0.87 | 1.18 | 1.339 | 1.254 | 0.984 | 1.061 | 1.126 | 0.947 | 0.995 | 0.987 | 0.589 | 1.05 | 1.156 | 1.216 | 1.296 | 1.285 | 1.275 | -0.331 | 1.046 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1.407 | 1.794 | 2.055 | 2.495 | 2.313 | 2.267 | 2.114 | 1.673 | 1.474 | 1.221 | 1.015 | 1.349 | 1.695 | 2.3 | 2.26 | 2.606 | 2.375 | 0.04 | 1.658 | 0 | 0 | 0 | 0 |
| Operating Income
| -1.437 | -1.823 | -2.08 | -2.517 | -2.327 | -2.273 | -2.123 | -1.682 | -1.484 | -1.23 | -1.027 | -1.346 | -1.694 | -2.299 | -2.242 | -2.574 | -2.301 | -1.006 | -1.646 | 0 | 0 | 0 | 0 |
| Operating Income Ratio
| 0 | -2.813 | -2.683 | -4.346 | -1.79 | -28,064.691 | -11,794.444 | -33.441 | -29.124 | -5,642.844 | -8,023.43 | -14,632.446 | -2,073.936 | -2,275.8 | -123.283 | -82.638 | -36.429 | 0 | -138.313 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.034 | 0.035 | 0.045 | -0.184 | 0.882 | -0.275 | -0.517 | -0.476 | -0.422 | -0.243 | -0.06 | -0.063 | -0.019 | -0.005 | -0.002 | -0 | -0.011 | 0.016 | -0.001 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -1.403 | -1.788 | -2.035 | -2.702 | -1.445 | -2.549 | -2.64 | -2.157 | -1.906 | -1.473 | -1.087 | -1.409 | -1.713 | -2.303 | -2.244 | -2.574 | -2.312 | -0.99 | -1.647 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0 | -2.759 | -2.625 | -4.664 | -1.112 | -31,465.593 | -14,668.172 | -42.897 | -37.401 | -6,758.862 | -8,493.82 | -15,315.359 | -2,097.14 | -2,280.255 | -123.413 | -82.64 | -36.61 | 0 | -138.384 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.451 | -0.61 | -0.725 | -0.563 | -0 | -0 | -0.515 | -0 | 0.037 | -0.42 | -0 | 0.9 | 0 | 1.429 | 0 | 1.024 | -0.187 | -0.187 | 0.748 | 0 | 0 | 0 | 0 |
| Net Income
| -0.951 | -1.178 | -1.31 | -2.139 | -1.445 | -2.549 | -2.125 | -2.157 | -1.943 | -1.053 | -1.087 | -0.509 | -1.713 | -0.874 | -2.244 | -1.55 | -2.312 | -0.803 | -0.899 | 0 | 0 | 0 | 0 |
| Net Income Ratio
| 0 | -1.818 | -1.69 | -3.692 | -1.112 | -31,465.593 | -11,806.617 | -42.897 | -38.124 | -4,830.234 | -8,493.82 | -5,533.38 | -2,097.14 | -865.28 | -123.413 | -49.758 | -36.61 | 0 | -75.521 | 0 | 0 | 0 | 0 |
| EPS
| -0.018 | -0.022 | -0.025 | -0.05 | -0.04 | -0.08 | -0.067 | -0.087 | -0.082 | -0.045 | -0.047 | -0.022 | -0.073 | -0.037 | -0.096 | -0.066 | -0.11 | -0.038 | -0.046 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -0.018 | -0.022 | -0.025 | -0.05 | -0.04 | -0.08 | -0.067 | -0.087 | -0.082 | -0.045 | -0.047 | -0.022 | -0.073 | -0.037 | -0.096 | -0.066 | -0.11 | -0.038 | -0.046 | 0 | 0 | 0 | 0 |
| EBITDA
| -1.407 | -1.794 | -2.055 | -2.495 | -2.313 | -2.267 | -2.114 | -1.673 | -1.474 | -1.221 | -1.015 | -1.335 | -1.684 | -2.289 | -2.226 | -2.562 | -2.266 | -0.975 | -1.624 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| 0 | -2.768 | -2.651 | -4.308 | -1.78 | -27,984.815 | -11,745.389 | -33.27 | -28.921 | -5,600.826 | -7,932.336 | -14,513.261 | -2,061.635 | -2,265.85 | -122.403 | -82.246 | -35.876 | 0 | -136.429 | 0 | 0 | 0 | 0 |